Activation, interaction and intimation of Nrf2 pathway and their mutational studies causing Nrf2 associated cancer

Mridul Sahu1, Utkarsh Jain1

  • 1School of Health Sciences and Technology (SoHST), UPES, Bidholi, Dehradun - 248007, India.

Insights

Molecular hydrogen activates the Nrf2 pathway, a key defense against oxidative stress and disease. This process involves molecular hydrogen interacting with Keap1, stabilizing Nrf2 and reducing harmful reactive oxygen species.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Signaling

Background:

  • Infection responses generate cytokines, leading to reactive oxygen species (ROS) and reactive nitrogen species (RNS) that damage cellular components and contribute to diseases like cancer.
  • The Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway is a critical cellular defense mechanism against oxidative stress.

Purpose of the Study:

  • To elucidate the mechanism by which molecular hydrogen activates the Nrf2 pathway.
  • To understand how Nrf2 activation mitigates oxidative damage and prevents disease.

Main Methods:

  • The study focuses on the molecular interactions within the Nrf2-Keap1 pathway.
  • Investigated the role of specific motifs (DLG, ETGE) in Nrf2-Keap1 binding and Nrf2 degradation.
  • Examined the effect of molecular hydrogen on Keap1 and subsequent Nrf2 stabilization.

Main Results:

  • Under oxidative stress, Keap1 undergoes conformational changes, stabilizing Nrf2.
  • Nrf2 translocates to the nucleus, inducing the transcription of antioxidant genes (SOD, GSH, CAT).
  • Molecular hydrogen activates Nrf2 by oxidizing iron porphyrin, which acts as an electrophile interacting with Keap1 cysteine residues, thereby preventing oxidative stress.

Conclusions:

  • Molecular hydrogen serves as a therapeutic agent by activating the Nrf2 pathway.
  • Nrf2 pathway activation is crucial for cellular protection against oxidative damage and disease development.
  • Targeting the Nrf2-Keap1 interaction with agents like molecular hydrogen offers a promising strategy for disease prevention.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
9.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.1K